The pharmaceutical landscape is shifting toward mineral-based gastrointestinal treatments, placing a premium on the ability to buy diosmectite powder in bulk through verified, high-precision channels. As clinical reliance on non-systemic adsorbents grows, procurement teams are moving past transactional relationships. They are now prioritizing integrated partnerships that guarantee...